About One in Five Adults Experienced Anxiety, Depression in 2022
THURSDAY, Nov. 7, 2024 -- About one in five adults experienced any symptoms of anxiety and symptoms of depression during 2022, according to a study published online Nov. 7 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.
Emily P. Terlizzi, M.P.H., and Benjamin Zablotsky, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, used data from the 2022 National Health Interview Survey to examine the prevalence of symptoms of anxiety and depression using the Generalized Anxiety Disorder scale and the Patient Health Questionnaire depression scale.
The researchers found that 18.2 and 21.4 percent of adults experienced any symptoms of anxiety or symptoms of depression, respectively, in the past two weeks during 2022. Symptom severity differed by sociodemographic and geographic characteristics. Adults aged 18 to 29 years had the highest percentage of mild, moderate, or severe symptoms of anxiety or depression; the percentages decreased with age and were higher among women than men. Compared with other race and Hispanic-origin groups, Asian non-Hispanic adults were least likely to experience moderate and severe symptoms of anxiety and depression. The highest percentage of adults with any symptoms of anxiety and depression was seen for those with less than a high school education and with family incomes less than 100 percent of the federal poverty level, as well as among those living in rural areas.
"A significant increase was seen in the percentage of adults with anxiety symptoms and depression symptoms between 2019 and 2022," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Dementia Odds Significantly Increase With More Psychiatric Comorbidities
WEDNESDAY, Sept. 10, 2025 -- Dementia odds significantly increase with the number of psychiatric comorbidities, according to a study published online Sept. 9 in BMJ Mental...
Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder
WEDNESDAY, Sept. 10, 2025 -- A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder...
Adjunctive Ketogenic Diet Beneficial for Major Depressive Disorder
WEDNESDAY, Sept. 10, 2025 -- A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.